Moisand Fitzgerald Tamayo’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.2K | Hold |
400
| – | – | ﹤0.01% | 235 |
|
|
2025
Q1 | $32.4K | Hold |
400
| – | – | ﹤0.01% | 228 |
|
|
2024
Q4 | $36K | Hold |
400
| – | – | 0.01% | 224 |
|
|
2024
Q3 | $39.5K | Hold |
400
| – | – | 0.01% | 214 |
|
|
2024
Q2 | $37.1K | Hold |
400
| – | – | 0.01% | 199 |
|
|
2024
Q1 | $38K | Hold |
400
| – | – | 0.01% | 200 |
|
|
2023
Q4 | $35.7K | Hold |
400
| – | – | 0.01% | 205 |
|
|
2023
Q3 | $29.2K | Hold |
400
| – | – | 0.01% | 224 |
|
|
2023
Q2 | $33.3K | Hold |
400
| – | – | 0.01% | 206 |
|
|
2023
Q1 | $30.5K | Hold |
400
| – | – | 0.01% | 220 |
|
|
2022
Q4 | $33.2K | Hold |
400
| – | – | 0.01% | 202 |
|
|
2022
Q3 | $32K | Hold |
400
| – | – | 0.01% | 193 |
|
|
2022
Q2 | $30K | Buy |
+400
| New | +$30K | 0.01% | 193 |
|
|
2017
Q4 | – | Sell |
-500
| Closed | -$43K | – | 318 |
|
|
2017
Q3 | $43K | Buy |
+500
| New | +$43K | 0.03% | 119 |
|